As shown by Figure 7A, compared with the non-chromothripsis group (n=19), tumors with chromothripsis (n=32) have a higher frequency of mutations in the VCAN and KIAA1109 genes, which are related to immunotherapeutic efficiency and prognosis in several types of cancer (23, 24). Here, VCAN is linked to cancer.